Show simple item record

Dupilumab reduced severe exacerbation rates and improved pre-bronchodilator Fev 1 in patients with moderate-to-severe asthma regardless of exacerbation history of 蠅1, 蠅2, or 蠅3 prior exacerbations: Liberty Asthma Traverse

dc.contributor.authorMaspero, JF
dc.contributor.authorCorren, J
dc.contributor.authorKatelaris, C
dc.contributor.authorCastro, M
dc.contributor.authorHumbert, MJC
dc.contributor.authorHalpin, DMG
dc.contributor.authorAltincatal, A
dc.contributor.authorPandit-Abid, N
dc.contributor.authorSoler, X
dc.contributor.authorRadwan, A
dc.contributor.authorJacob-Nara, JA
dc.contributor.authorDeniz, YM
dc.contributor.authorRowe, PJ
dc.date.accessioned2023-06-22T13:39:34Z
dc.date.issued2023-05-23
dc.date.updated2023-06-21T10:59:24Z
dc.description.sponsorshipSanofi and Regeneron Pharmaceuticals, Inc.en_GB
dc.format.extenta4742-a4742
dc.identifier.citationVol. 207, article A4742en_GB
dc.identifier.doihttps://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4742
dc.identifier.urihttp://hdl.handle.net/10871/133481
dc.identifierORCID: 0000-0003-2009-4406 (Halpin, DMG)
dc.identifierScopusID: 57419799500 | 7005149597 (Halpin, DMG)
dc.language.isoenen_GB
dc.publisherAmerican Thoracic Societyen_GB
dc.rights.embargoreasonUnder embargo until 23 May 2024 in compliance with publisher policyen_GB
dc.rights© 2023 American Thoracic Society, All Rights Reserved.en_GB
dc.subjectRespiratoryen_GB
dc.titleDupilumab reduced severe exacerbation rates and improved pre-bronchodilator Fev 1 in patients with moderate-to-severe asthma regardless of exacerbation history of 蠅1, 蠅2, or 蠅3 prior exacerbations: Liberty Asthma Traverseen_GB
dc.typeConference paperen_GB
dc.date.available2023-06-22T13:39:34Z
dc.identifier.issn1073-449X
dc.descriptionThis is the author accepted manuscript. The final version is available from the American Thoracic Society via the DOI in this record en_GB
dc.identifier.eissn1535-4970
dc.identifier.journalAmerican Journal of Respiratory and Critical Care Medicineen_GB
dc.relation.ispartofC31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2023-05-23
rioxxterms.typeConference Paper/Proceeding/Abstracten_GB
refterms.dateFCD2023-06-22T13:34:45Z
refterms.versionFCDAM
refterms.dateFOA2024-05-22T23:00:00Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-05-23
pubs.name-of-conferenceC31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD


Files in this item

Name:
Corren_TRAV exacerb hx_ ATS ...
Size:
85.14Kb
Format:
PDF
Description:
Dupilumab Reduced Severe Exace ...
View/Open

This item appears in the following Collection(s)

Show simple item record